Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05432479

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

This study evaluates the efficacy of single strain probiotic administered in a form of a sachet in the treatment of infant colic in infants 3-12 weeks old.

Recruiting

Interested in participating?

Request Info

Key information

Age range

3 week–12 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pulse Multispeciality Hospital,, Pune, Maharashtra, India

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gestational age of minimum 37 weeks.
  • Birthweight of minimum 2500 g (5.5 lb.).
  • Age of greater than 3 weeks and less than 12 weeks at enrolment.
  • Confirmed Infantile colic defined as: parental report of crying and/or fussing ≥3 hours/day for ≥3 days/week, confirmed prior to enrolment with an infant behaviour diary recording >3 hours of crying in a 24-hour period (eDiary App completed daily during run-in period & for duration of study).
  • Participant Informed Consent form signed by parent or legal guardian.
  • Infant is considered healthy following physical exam.
  • Parents/Caregivers are willing to comply with the trial procedures, and the mother of the infant can attend all three trial visits

Exclusion criteria

  • Use of antibiotics by the infant within 2-weeks prior to the screening visit or during the run-in period of the trial.
  • Use of probiotic supplements from child's birth to enrolment (this includes infant formulas containing probiotics).
  • Need for hospitalization (defined as readmission to a hospital ward after initial discharge following delivery).
  • Congenital disorders that, in the opinion of the investigator, would impact the gastrointestinal tract.
  • Failure to thrive.
  • Known lactose or gluten intolerance.
  • Known allergy to cow's milk proteins, fish, or any of the substances of the trial product or placebo.
  • Known other causes for abdominal pain (e.g., pyloric stenosis).
  • Participation in any other interventional clinical study.
  • Immuno-compromised participant or participant with other severe chronic disorder.
  • Use of probiotic supplements by breastfeeding mother from child's birth to enrolment.
  • Use of antibiotics by breastfeeding mother within 2-weeks prior to the screening visit or during the run-in period of the trial.
  • Any Participant/Parent/Caregiver who is an employee of the investigational site or an Atlantia Clinical Trials employee or their close family member or a member of their household.

Treatment and study plan

Probiotic

Dietary Supplement

Single strain probiotic in a form of a sachets with a daily dose of 1.0E+9 Colony Forming Unit (CFU) per day for 4 weeks

Placebo

Dietary Supplement

Placebo

Primary outcomes

  1. Change in cry and fuss time

    Time frame: Day 0 , Day 28

    eDiary parent reported cry and fuss time

Secondary outcomes

  1. Resolution of colic symptoms

    Time frame: Day 0, Day 28

    Reduction of cry and fuss time (parent reported) greater than 90% comparing to baseline

  2. Change in cry and fuss time bouts

    Time frame: Day 0, Day 28

    eDiary parent reported cry and fuss bouts

  3. Change in sleeping time

    Time frame: Day 0 Day 28

    eDiary parent reported sleep time

  4. Change in the use of rescue medications

    Time frame: Day 0, Day 28

    Change in the proportion of participants needing to use rescue medications between the study arms

Other outcomes

  1. Change in maternal quality of life and mental health

    Time frame: Day 0, Day 28

    Change in maternal QoL using WHO QOL/BREF (improvement marked by increase in the total score)

  2. Change in maternal quality of life and mental health

    Time frame: Day 0, Day 28

    Change in maternal QoL using MMPP/QoL (improvement marked by increase in the total score)

Study contacts

Contact information is provided by the study sponsor or research team.

ADM Medical Team

CONTACT

[email protected]

+44 1460 243 230

Sponsors and collaborators

Lead sponsor

The Archer-Daniels-Midland Company

Industry

Collaborators

  • Atlantia Food Clinical Trials
  • Vedic Lifesciences Pvt. Ltd.

Registry information

Official study title

A Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

Acronym: PIXAR

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Jun 27, 2022
Registry last updated
Apr 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.